Science & Enterprise subscription

Follow us on Twitter

  • Genny Cream for me, if I were there https://t.co/BQcWbr7yLh
    about 1 hour ago
  • As the race to produce and distribute Covid-19 vaccines intensifies, financing of this global public health project… https://t.co/pyDX0IWnCs
    about 7 hours ago
  • New post on Science and Enterprise: Infographic – Public Money Funds Covid-19 Vaccines https://t.co/1D2XLhUi4Z #Science #Business
    about 7 hours ago
  • Excellent analysis. Real example: a colleague I hired at Science mag is leaving her job to get a grad degree in IT. https://t.co/c0qnYW025H
    about 10 hours ago
  • Two biotechnology companies are collaborating on using the gene editing technique Crispr to create engineered immun… https://t.co/4lK4qD5p6m
    about 1 day ago

Please share Science & Enterprise

Biotechs Partner on Gene-Edited Cancer Cell Therapies

Natural killer cell

Two biotechnology companies are collaborating on using the gene editing technique Crispr to create engineered immune-system cells to treat cancer. . . . → Read More: Biotechs Partner on Gene-Edited Cancer Cell Therapies

Gene Therapy Company Exploring DNA Circuit Technology

Circuit graphic

Spark Therapeutics, a developer of gene therapies, is gaining access to a technology that programs DNA sequences like integrated electronic circuits. . . . → Read More: Gene Therapy Company Exploring DNA Circuit Technology

Univ. Lab Develops, Licenses Sports Injury Implant

Pitcher Matt Grace

A medical device company now offers a synthetic tissue implant for torn rotator cuff, a common sports injury, designed at a Purdue University engineering lab. . . . → Read More: Univ. Lab Develops, Licenses Sports Injury Implant

AbbVie Licenses Engineered Crispr Cell Process

Drug maker AbbVie is acquiring a technology using the gene-editing process Crispr to produce new off-the-shelf engineered T-cells as disease therapies. . . . → Read More: AbbVie Licenses Engineered Crispr Cell Process

Cancer Immunotherapy Adapted for HIV

T-cell infected by HIV

A biotechnology company is adapting and licensing its immunotherapy process, originally designed for cancer, as a cure for HIV infections. . . . → Read More: Cancer Immunotherapy Adapted for HIV

Institutions Join Global Health Breakthrough Network

Networked earth

Wellcome Leap aims to establish a model for faster design and development of health breakthroughs, beginning with elimination of administrative obstacles. . . . → Read More: Institutions Join Global Health Breakthrough Network

Universities Form Joint Engineering Patent Pool

U.S. Patent and Trademark Office

A group of 15 American universities are putting part of their engineering patents into a common licensing pool for commercial development. . . . → Read More: Universities Form Joint Engineering Patent Pool

Biotech Licenses mRNA Technology for Aging

Hands of older person

A biotechnology enterprise is licensing research from Stanford University on messenger RNA to produce proteins that rejuvenate cells damaged by aging. . . . → Read More: Biotech Licenses mRNA Technology for Aging

Drug Maker Gains Access to Hidden Protein Immunotherapies

T-cells and cancer cells

Global drug maker Boehringer Ingelheim is gaining access to an immunotherapy technology that targets usually hidden proteins to attack cancer cells. . . . → Read More: Drug Maker Gains Access to Hidden Protein Immunotherapies

AbbVie Acquires Coronavirus Antibody Therapy

SARS-Cov-2 virus

Drug maker AbbVie is licensing a synthetic antibody to treat Covid-19 and SARS coronaviruses that the company began funding in June. . . . → Read More: AbbVie Acquires Coronavirus Antibody Therapy